Maine SUD Learning Community cover art

All Episodes

Maine SUD Learning Community — 159 episodes

#
Title
1

340 | PMP Series | Beers Criteria and Alternatives for Older Adults

2

339 | 1115 Waiver | Correctional Legal ECHO: Intersection of Corrections and Healthcare

3

338 | Mi'kmaq Nation Naloxone Vending Machine

4

337 | PMP Series | Clinical Cannabis and Prescribing Considerations

5

336 | PMP Series | Approaching ADHD Diagnosis and Treatment: Embracing the Complexity

6

335 | Innovations in Opioid Use Disorder Treatment

7

334 | Building a Culture of Safety: Trauma-Informed Systems, Stigma Reduction, and Workforce Sustainability

8

333 | Correctional Legal ECHO: Intersection of Corrections and Healthcare | Extended Release Buprenorphine in Jails

9

332 | Opioid Use Disorder: Epidemiology and Evidence-Based Pharmacotherapy

10

331 | PMP Series: Medetomidine and Withdrawal

11

330 | Treatment and Recovery Court | Correctional Legal ECHO: Intersection of Corrections and Healthcare

12

329 | Understanding Eating Disorders in Youth and the Intersection They Have With Substance Use

13

328 | Updates in HIV PrEP

14

327 | Guidelines for the Use of Human Milk in the Context of Substance Use Disorder

15

326 | Creating a Recovery Center in Rural Communities

16

325 | Peer Recovery Coaching and Reentry | Correctional Legal ECHO: Intersection of Corrections and Healthcare

17

324 | Methadone Safety and Current Dosing in Opioid Use Disorder

18

323 | The Modern Illicit Drug Environment, Adulterants, Trends, and Threats

19

322 | PMP Series | Overdose Reversal Medications

20

321 | Medication and Treatment for Cannabis Use Disorder

21

319 | Infectious Disease Syndemic and Substance Use in Maine: From Surveillance to Action

22

320 | Correctional Legal ECHO: Intersection of Corrections and Healthcare

23

318 | Alcohol and Cognition: Neurobiology, Neurocognitive Profiles, and Clinical Implications for Assessment and Treatment

24

317 | Behavioral and Psychological Symptoms of Dementia

25

316 | Coordinating Initiation and Continuation of Health Services | Correctional Legal ECHO

26

314 | Psychedelic-Assisted Mental Health Treatment

27

313 | Psychosis and Substance Use in Adolescents and Young Adults

28

312 | PMP Series | Considerations for Benzodiazepine Tapering

29

311 | Management of Fetal Alcohol Spectrum Disorders: Changing the Environment can Change Everything

30

315 | Arrests and Definitions | Correctional Legal ECHO: Intersection of Corrections and Healthcare

31

310 | The ABCs of Anxiety and Zzzs: Benzodiazepines and Z-Drugs Explained

32

309 | Medication Deprescribing

33

308 | PMP Series: Drivers and Impacts of Drug Diversion among College Students

34

307 | Exploring the Role of Prescription Stimulants in Treating Stimulant Use Disorder: Rationale, Evidence and Clinical Applications

35

306 | PMP Series | Buprenorphine Beyond OUD: Chronic Pain and Opioid Stewardship

36

305 | PMP Series | Stimulant Misuse and Prevention in College Students

37

304 | The Intersection of Reproductive Health, Contraceptive Care, and Incarceration

38

303 | Cannabis Hyperemesis Syndrome in Adolescents and Young Adults

39

302 | Nitrous Oxide Abuse: An Increasingly Common Substance of Abuse

40

301 | PMP Series | Opioids and Beyond: Safe Strategies for Chronic Pain Treatment

41

289 | Bridging the Gap: Screening and Accommodations for Patients with TBI in Substance Use Treatment

42

291 | Driving Fitness, Health, & Aging: Medical-Functional Conditions and Driver Licensing in Maine

43

290 | Developing Co-Occurring Competency: A Supervisor's Guide

44

287 | Prenatal Alcohol Exposure, Substance Use Disorder, and Navigating Recovery

45

286 | Low Barrier Care for Substance Use Treatment

46

288 | Medications for Older Adults with AUD | Older Adult ECHO: Responsive Care for Aging Adults with SUD

47

285 | How Do Adulterants Like Quinine, Metamizole, Xylazine, and Medetomidine Impact the Opioid Epidemic?

48

284 | A Comprehensive Approach to Incarcerated Individuals with Substance Use Disorder: Systems Change at Franklin County Jail

49

283 | On The Road to Recovery: Maine's Mobile Methadone Unit

50

282 | Best Practices When Working with Medical Interpreters

51

281 | Addressing the Impact of Substance Use Stigma in Maine

52

280 | Cannabis Toolkit: A Resource for Service Providers Working with Youth

53

279 | Withdrawal Management Case Studies for Nurses

54

277 | PMP Series | Buprenorphine for Chronic Pain through Positive Childhood Experiences and Positive Psychology

55

276 | Beyond Awareness: Evidence-Based Strategies for Reducing Stigma in Clinical Practice

56

278 | Older Adult ECHO: Responsive Care for Aging Adults with SUD | Anxious Aging: Practical Tools for Recognition and Relief

57

275 | Integrating Care for Complex Needs: FASD, Polysubstance Exposure, and Trauma

58

274 | The Ripple Effect: Social Impacts on Youth Substance Use | Young Adult ECHO: Treating Adolescent Substance Use

59

273 | Long term treatment of Alcohol Use Disorder (AUD)

60

272 | Differentiating "Gas Station Heroin" from Leaf Kratom: Preventing Fourth Wave of Opioid Epidemic

61

271 | Family Centered Approach | Young Adult ECHO: Treating Adolescent Substance Use

62

270 | Consent and Confidentiality Issues for Adolescents

63

269 | Enhancing the Efficacy of Brief Alcohol and Drug Use Interventions for Higher-Risk Emerging Adults

64

267 | Integrated Skill-based Interventions for People with Co-occurring Conditions, Part 4 of 4

65

268 | Accessible Wellness: Mindfulness and Relaxation Practices for Your Workday

66

266 | Older Adult ECHO: Responsive Care for Aging Adults with SUD | "I'm Still Me": Providing individualized care to Older Adults

67

265 | Young Adult ECHO | Confidentiality: Mental Health versus Substance Use Laws- What's the Difference

68

264 | Portland Public Health's Overdose Data to Action: LOCAL Community Needs Assessment

69

265 | Buprenorphine Use in Special Populations

70

263 | PMP Series | An Opioid Epidemic: The Healthcare Professional's Role in Prevention

71

262 | Sudden Unexpected Infant Death and Infant Safe Sleep in Maine

72

261 | Fetal Alcohol Spectrum Disorders: Screening, Diagnosis, and Intervention

73

258 | Methadone Initiations in the Fentanyl Era: New SAMHSA Rules, New Drug Supply... Same Dosing Protocols?

74

260 | YA ECHO: Treating Adolescent Substance Use | Reaching Adolescents and Young Adults (AYA) Where They Are

75

259 | Older Adult ECHO: Responsive Care for Aging Adults with SUD | End of Life Care with SUD

76

257 | Implementing Rural Community Transportation Services for Behavioral Health Services

77

256 | CONNECT Outreach Van: Mobile Psychiatry and Substance Use Disorder Treatment for People Experiencing Homelessness

78

254 | YA ECHO: Treating Adolescent Substance Use | Assessing and Screening: What Works and What Changes are on the Horizon with ASAM

79

255 | Integrated Stage-Matched Interventions for People with Co-occurring Conditions | part 3 of 4

80

252 | Integrated Stage-Matched Treatment/Recovery Planning | Part 2 of 4

81

251 | Integrated Longitudinal Strength-Based Assessment (ILSA) | Part 1 of 4

82

253 | PMP Series | Understanding the Current Uses and Misuse of Gabapentin

83

250 | Integration of Traditional Cultural Practices in Behavioral Health Services

84

249 | YA ECHO: Treating Adolescent Substance Use | Key Development Issues: Risks and Resiliency

85

248 | Methadone for Opioid Use Disorder for the Generalist: Everything you wanted to know but were afraid to ask

86

247 | Buprenorphine Formulations

87

246 | Why Cannabis is NOT the Solution for PTSD

88

245 | Truth or Hysteria Investigating Cannabis - Fentanyl Contamination

89

244 | Caring for Affected Others: The Secondary Impact of the Opioid Crisis

90

243 | Creating Welcoming, Recovery-Oriented, Co-occurring-Capable Services COMPASS-EZ™, Part 2

91

242 | Understanding your Organizational Baseline using the COMPASS-EZ™, Part 1

92

241 | Supporting Parents and Guardians with Alcohol Use Disorder: Strategies to Promote Recovery and Family Well-Being

93

240 | A Discussion about the Special Report by the Maine Accidental Drug Overdose Death Review Panel of Adolescent Cases

94

239 | PMP Series | Trauma-Informed Deprescribing: How to Align with Patients While Prescribing Responsibly

95

238 | Low Dose Initiation of Buprenorphine

96

237 | Indigenous ECHO: Strengthening Indigenous Responsiveness | Culturally Respectful Care for Substance Use Disorders

97

236 | Applying a Harm Reduction Lens to PrEP Prescribing

98

235 | Wabanaki Public Health & Wellness: The Road to Creating Substance Use Disorder Programming

99

234 | Ketamine Therapy for Substance Use Disorders: Theory, Evidence, and Limitations

100

233 | Addressing the Specific Needs of Women with Substance Use Disorder

101

232 | Understanding and Reducing Health Stigma

102

231 | 2-C Drugs and Novel Psychoactive Substances in New England

103

230 | Adolescent ECHO: Adolescent Medicine: How SUD Fits | Confidentiality for Adolescents

104

229 | Care for Alcohol Use Disorder Using the Right Tools for the Job

105

228 | Identifying and Closing Gaps in Care for Mainers with Opioid Use Disorder (OUD)

106

227 | High Dose Buprenorphine Inductions The Who, What, Where, When, Why, and How

107

226 | RX ECHO SUD: Through a Pharmacy Lens | Standing Orders

108

225 | Indigenous ECHO: Strengthening Indigenous Responsiveness | Cultural Responses to Substance Use Services

109

224 | Critical Updates in Overdose Prevention

110

223 | The Intersection of Homelessness and Infectious Disease

111

222 | Adolescent ECHO: Adolescent Medicine | How to Make Your Practice Adolescent and Young Adult Friendly

112

221 | RX ECHO: SUD Through a Pharmacy Lens | OD Prevention

113

220 | The Community Care Team Model

114

219 | Project ECHO: SUD Through a Pharmacy Lens | Harm Reduction

115

218 | Buprenorphine During Pregnancy and Postpartum

116

217 | Indigenous ECHO: Strengthening Indigenous Responsiveness | Mi’kmaq Nation Naloxone Vending Machine

117

216 | Planning for Success: Shared Decision-Making and Outpatient Transition From Fentanyl to Buprenorphine

118

215 | YA ECHO Adolescent Medicine: How SUD Fits | Navigating the Impact of Addictive Technology on Student Mental Health: A Focus on Social Media and AI

119

214 | PMP Series | Cannabis Use During Pregnancy Research from Policy to Practice

120

213 | RX ECHO | SUD Through a Pharmacy Lens: Stigma

121

212 | Talking with Youth and Families (with MH issues) about Substance Use Podcast

122

211 | Strategies for Psychopharmacology for Individuals with Co-Occurring Psychiatric and substance use disorders

123

210 | Older Adults and Substance Use Disorders Trends and Supportive Interventions

124

209 | Integrating HIV testing into street outreach for unhoused Mainers

125

208 | Adolescent ECHO: Adolescent Medicine: How SUD Fits | Eating Disorders

126

207 | PMP Series | Fostering Positive Bonds: Supporting Youth and Families Affected by AUD

127

206 | Brief introduction to Integrating Peer Support Roles into Multidisciplinary Teams

128

205 | Welcoming, Integrated Services for People with Co-Occurring Disorders

129

204 | Contingency Management: An Overview, and our Implementation at MaineHealth

130

203 | Addressing the Intersection: HIV, Substance Use Disorders, and Evidence-based Approaches to Care

131

202 | MOUD: Medications for Opioid Use Disorder

132

201 | The Value of Applying Harm Reduction Principles in Clinical Relationships

133

127 | HIV & SUD in Maine: How one county's recent HIV cluster highlights important links between SUD & HIV

134

126 | Evidence-Based Practices in SUD

135

125 | Methadone and the Oral Cavity

136

124 | Harm Reduction Efforts in Rural Maine

137

123 | Welcoming Spaces: Trauma Informed Care for People with SUD

138

122 | Project ECHO: Methadone in the Age of Fentanyl | Drug Interactions with Methadone

139

121 | Initiation of Maintenance Medications for Alcohol and Opioid Use Disorders for Nursing

140

120 | Contingency Management Implementation in Maine

141

119 | Xylazine: What We Need to Know

142

118 | Evidence Based Practices for Contingency Management

143

117 | Polysubstance/Complex Withdrawal Management for Nursing

144

116 | Quality Improvement Models to Support Implementation, Improvement and Expansion of MOUD and Evidence Based SUD Practices

145

115 | Project ECHO: Methadone in the Age of Fentanyl | Transitions in Methadone and Buprenorphine

146

114 | Best and Promising Practices | Interview of Kristen Silvia, MD

147

113 | Inpatient Treatment of Alcohol Withdrawal Syndrome

148

112 | Hospital Care of the Opioid Exposed Newborn

149

111 | Identifying and Supporting People Impacted by Intimate Partner Violence and Substance Use

150

110 | Best and Promising Practices | SaVida Health OHH Model - Expanding the Boundaries

151

109 | Best and Promising Practices | Northern Light Inpatient Pharmacy - Advancing MOUD with Whitney Jandreau

152

108 | Best and Promising Practices | Community Care and Geriatrics: Responding to the needs of patients with OUD/SUD in post-acute and long-term care

153

107 | Groups Recover Together: How they deliver (and measure) outcome

154

106 | Best and Promising Practice | St Joseph’s Healthcare XR Buprenorphine Practice: Successes and Challenges

155

105 | Best and Promising Practice | PenBay Family Medicine Rockport: Making Effective Workflows in Primary Care

156

104 | Best and Promising Practice | Gilman Clinic: Tips on Treating Hepatitis C in Individuals with SUD/OUD

157

103 | Best and Promising Practice | Integration of Peers into Medical Practices Treating SUD with Randy Morrison

158

102 | Promising Practices | Expanding Treatment Programs to Higher Acuity Patients

159

101 | Best and Promising Practices | York Recovery Center: Creating Rapid Access and Medications First